These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26744530)

  • 61. Decreased tumorigenesis in mice with a Kras point mutation at C118.
    Huang L; Carney J; Cardona DM; Counter CM
    Nat Commun; 2014 Nov; 5():5410. PubMed ID: 25394415
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway.
    Kang R; Tang D; Lotze MT; Zeh HJ
    Autophagy; 2012 Jun; 8(6):989-91. PubMed ID: 22722139
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors.
    Zhong H; Davis A; Ouzounova M; Carrasco RA; Chen C; Breen S; Chang YS; Huang J; Liu Z; Yao Y; Hurt E; Moisan J; Fung M; Tice DA; Clouthier SG; Xiao Z; Wicha MS; Korkaya H; Hollingsworth RE
    Cancer Res; 2016 Jan; 76(2):480-90. PubMed ID: 26744529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CBX4 deletion promotes tumorigenesis under Kras
    Chen F; Hou W; Yu X; Wu J; Li Z; Xu J; Deng Z; Chen G; Liu B; Yin X; Yu W; Zhang L; Xu G; Ji H; Liang C; Wang Z
    Signal Transduct Target Ther; 2023 Sep; 8(1):343. PubMed ID: 37696812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.
    Rabe B; Chalaris A; May U; Waetzig GH; Seegert D; Williams AS; Jones SA; Rose-John S; Scheller J
    Blood; 2008 Feb; 111(3):1021-8. PubMed ID: 17989316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
    Xie Y; Sahin M; Wakamatsu T; Inoue-Yamauchi A; Zhao W; Han S; Nargund AM; Yang S; Lyu Y; Hsieh JJ; Leslie CS; Cheng EH
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Senescent Macrophages Promote KRAS-Driven Lung Tumorigenesis.
    Cancer Discov; 2023 Aug; 13(8):1758. PubMed ID: 37326376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.
    Chen X; Wei J; Li C; Pierson CR; Finlay JL; Lin J
    Int J Oncol; 2018 Feb; 52(2):571-578. PubMed ID: 29207075
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oncogenic context shapes the fitness landscape of tumor suppression.
    Blair LM; Juan JM; Sebastian L; Tran VB; Nie W; Wall GD; Gerceker M; Lai IK; Apilado EA; Grenot G; Amar D; Foggetti G; Do Carmo M; Ugur Z; Deng D; Chenchik A; Paz Zafra M; Dow LE; Politi K; MacQuitty JJ; Petrov DA; Winslow MM; Rosen MJ; Winters IP
    Nat Commun; 2023 Oct; 14(1):6422. PubMed ID: 37828026
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras-driven lung tumours.
    Närhi K; Nagaraj AS; Parri E; Turkki R; van Duijn PW; Hemmes A; Lahtela J; Uotinen V; Mäyränpää MI; Salmenkivi K; Räsänen J; Linder N; Trapman J; Rannikko A; Kallioniemi O; Af Hällström TM; Lundin J; Sommergruber W; Anders S; Verschuren EW
    J Pathol; 2018 May; 245(1):101-113. PubMed ID: 29443392
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.
    Du T; Li H; Fan Y; Yuan L; Guo X; Zhu Q; Yao Y; Li X; Liu C; Yu X; Liu Z; Cui CP; Han C; Zhang L
    Nat Commun; 2019 Jul; 10(1):2914. PubMed ID: 31266968
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.
    Lei Y; Zang R; Lu Z; Zhang G; Huang J; Liu C; Wang Z; Mao S; Che Y; Wang X; Zheng S; Fang L; Sun N; He J
    Cell Death Dis; 2020 Oct; 11(10):853. PubMed ID: 33056994
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle.
    Conceição M; Forcina L; Wiklander OPB; Gupta D; Nordin JZ; Vrellaku B; McClorey G; Mäger I; Gӧrgens A; Lundin P; Musarò A; Wood MJA; Andaloussi SE; Roberts TC
    Biomaterials; 2021 Jan; 266():120435. PubMed ID: 33049461
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The integrated stress response in the induction of mutant KRAS lung carcinogenesis: Mechanistic insights and therapeutic implications.
    Koromilas AE
    Bioessays; 2022 Aug; 44(8):e2200026. PubMed ID: 35587163
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.
    Unver N; Delgado O; Zeleke K; Cumpian A; Tang X; Caetano MS; Wang H; Katayama H; Yu H; Szabo E; Wistuba II; Moghaddam SJ; Hanash SM; Ostrin EJ
    Int J Cancer; 2018 Apr; 142(7):1405-1417. PubMed ID: 29134640
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.
    Cai H; Chew SK; Li C; Tsai MK; Andrejka L; Murray CW; Hughes NW; Shuldiner EG; Ashkin EL; Tang R; Hung KL; Chen LC; Lee SYC; Yousefi M; Lin WY; Kunder CA; Cong L; McFarland CD; Petrov DA; Swanton C; Winslow MM
    Cancer Discov; 2021 Jul; 11(7):1754-1773. PubMed ID: 33608386
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.
    Rao S; Sigl V; Wimmer RA; Novatchkova M; Jais A; Wagner G; Handschuh S; Uribesalgo I; Hagelkruys A; Kozieradzki I; Tortola L; Nitsch R; Cronin SJ; Orthofer M; Branstetter D; Canon J; Rossi J; D'Arcangelo M; Botling J; Micke P; Fleur L; Edlund K; Bergqvist M; Ekman S; Lendl T; Popper H; Takayanagi H; Kenner L; Hirsch FR; Dougall W; Penninger JM
    Genes Dev; 2017 Oct; 31(20):2099-2112. PubMed ID: 29118048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion.
    Guilbaud E; Barouillet T; Ilie M; Borowczyk C; Ivanov S; Sarrazy V; Vaillant N; Ayrault M; Castiglione A; Rignol G; Brest P; Bazioti V; Zaitsev K; Lebrigand K; Dussaud S; Magnone V; Bertolotto C; Marchetti S; Irondelle M; Goldberg I; Huby T; Westerterp M; Gautier EL; Mari B; Barbry P; Hofman P; Yvan-Charvet L
    Cell Stem Cell; 2023 Jun; 30(6):800-817.e9. PubMed ID: 37267915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune modulatory effects of oncogenic KRAS in cancer.
    Hamarsheh S; Groß O; Brummer T; Zeiser R
    Nat Commun; 2020 Oct; 11(1):5439. PubMed ID: 33116132
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detection of Lung Tumor Progression in Mice by Ultrasound Imaging.
    Ghaddar N; Wang S; Michaud V; Kazimierczak U; Ah-Son N; Koromilas AE
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32176201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.